MIPS 2020—What’s New With the 2022 Bonuses and Penalties
Excerpted from MIPS—What’s New in 2020 for Ophthalmology (EyeNet, January 2020). Also see MIPS 2020: A Primer and Reference, which is being posted online ahead of print.
Harder to avoid the penalty. Your 2022 payments will be penalized if your 2020 MIPS final score falls below a performance threshold of 45 points (up from 30 points in 2019).
Maximum penalty will be –9%. If your 2020 MIPS final score falls below 11.25 points (up from 7.5 points in 2019), your 2020 Medicare Part B payments will be subject to the maximum penalty of –9% (up from –7%).
Harder to get a bonus. Score above the 45-point threshold and you will earn an initial bonus; score at least 85 points (up from 75 points in 2019), you also will qualify for an exceptional performance bonus. The initial bonus is budget-neutral, and it is funded by the penalties; the second bonus comes out of a separate $500 million–per-year fund.
|2020 MIPS Final Score
||2022 Payment Adjustment
||Maximum penalty of –9%
||Penalty of less than –6.75%*
||Initial bonus** + exceptional performance bonus**
|* This 2022 payment penalty is on a sliding scale, peaking at almost –6.75% for a 2020 MIPS final score of 11.26 points.
|** The two bonuses are on a sliding scale; the higher your 2020 MIPS final score, the higher your 2022 payment adjustment.
Next: MIPS 2020—What’s New With Quality
DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.
COPYRIGHT© 2020, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology.®